American Association for Cancer Research (AACR) Annual Meeting 2025 Poster Presentation: LB207: Continuous subcutaneous lenalidomide delivery improves the therapeutic index and avoids drug-related grade 3/4 hematologic toxicity in patients with relapsed/refractory multiple myeloma
Posted: April 25, 2025
Please view here, or download from the button below.